Evidence map›Paper›PMID 35124811›Full record

ArticleMedical physics2022

Time-resolved MRI for off-line treatment robustness evaluation in carbon-ion radiotherapy of pancreatic cancer.

Giorgia Meschini, Alessandro Vai, Amelia Barcellini, Giulia Fontana, Silvia Molinelli, Edoardo Mastella, Andrea Pella, Viviana Vitolo, Sara Imparato, Ester Orlandi and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Medical physics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Giorgia MeschiniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Alessandro VaiMedical Physics Unit, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Amelia BarcelliniClinical Department, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Giulia FontanaClinical Bioengineering Unit, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Silvia MolinelliMedical Physics Unit, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Edoardo MastellaMedical Physics Unit, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Andrea PellaClinical Bioengineering Unit, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Viviana VitoloClinical Department, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Sara ImparatoRadiology Unit, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Ester OrlandiClinical Department, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Mario CioccaMedical Physics Unit, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.
Guido BaroniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
Chiara PaganelliDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy.
National Center for Oncological Hadrontherapy · ITPolitecnico di Milano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn this study, we investigate the use of magnetic resonance imaging (MRI) for the clinical evaluation of gating treatment robustness in carbon-ion radiotherapy (CIRT) of pancreatic cancer. Indeed, MRI allows radiation-free repeated scans and fast dynamic sequences for time-resolved (TR) imaging (cine-MRI), providing information on inter- and intra-fraction cycle-to-cycle variations of respiratory motion. MRI can therefore support treatment planning and verification, overcoming the limitations of the current clinical standard, that is, four-dimensional computed tomography (4DCT), which describes an "average" breathing cycle neglecting breathing motion variability.

methodsWe integrated a technique to generate a virtual CT (vCT) from 3D MRI with a method for 3D reconstruction from 2D cine-MRI, to produce TR vCTs for dose recalculations. For eight patients, the method allowed evaluating inter-fraction variations at end-exhale and intra-fraction cycle-to-cycle variability within the gating window in terms of tumor displacement and dose to the target and organs at risk.

resultsThe median inter-fraction tumor motion was in the range 3.33-12.16 mm, but the target coverage was robust (-0.4% median D

conclusionsThis study proposed a method for the generation of TR vCTs from MRI, which enabled an off-line evaluation of gating treatment robustness and suggested its feasibility to support treatment planning of pancreatic tumors in CIRT.

Indexed as

Heavy Ion RadiotherapyPancreatic NeoplasmsCarbonFour-Dimensional Computed TomographyHumansMagnetic Resonance ImagingMovementRadiotherapy Planning, Computer-AssistedRespirationCarboncarbon-ion radiotherapymoving targetstime-resolved MRI

Identifiers

PMID35124811
PMCPMC9306947
OpenAlexW4210435486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.